FDA approves over-the-counter sales of lifesaving opioid overdose treatment Narcan nasal spray
Publishing timestamp: 2023-03-29 09:01:53
Summary
The FDA has approved the sale of Narcan, a nasal spray used to reverse opioid overdoses, without a prescription. The decision is expected to significantly expand access to the lifesaving treatment. The manufacturer, Emergent BioSolutions, has said that Narcan should be available without a prescription by late summer. The push to make Narcan easier to access is part of the FDA's efforts to fight the opioid crisis.
Sentiment: NEUTRAL
Tickers: EBS,
Keywords: u.s. economy, epidemics, business, pandemics, business news, breaking news: business, emergent biosolutions inc, disease outbreaks, health care industry, biotechnology, biotech and pharmaceuticals, coronavirus, politics,
Source: https://www.cnbc.com/2023/03/29/opioids-fda-approves-over-the-counter-sales-of-narcan-.html